{"brief_title": "Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes", "brief_summary": "This trial is conducted in the United States of America (USA). The purpose of this study is to test whether biphasic insulin aspart 70/30 is a safe and at least as effective alternative in combination with two oral anti-diabetics compared to the two oral anti-diabetics alone for the control of blood glucose.", "condition": ["Diabetes", "Diabetes Mellitus, Type 2"], "intervention_type": ["Drug", "Drug", "Drug"], "intervention_name": ["biphasic insulin aspart", "pioglitazone", "metformin"], "criteria": "Inclusion Criteria: - Subjects with type 2 diabetes mellitus", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Insulin, Globin Zinc", "Insulin degludec, insulin aspart drug combination", "Pioglitazone", "Insulin", "Metformin", "Biphasic Insulins", "Insulin Aspart", "Insulin, Long-Acting"], "id": "NCT00097279"}